"Whisper Numbers"

[Drmicrocap]

LOW beats the "Street" by .07

[Drmicrocap]

Whisper Number-LOW .81

[Drmicrocap]

Whisper Number: PCLN $13.50

[Drmicrocap]

IN THE NEWS:NTRS

[Drmicrocap]

IN THE NEWS: XRAY beats the "Street" by .02

[Drmicrocap]

IN THE NEWS: FB beats by .10

[Drmicrocap]

JCTCF Reports .21

[Drmicrocap]

IN THE NEWS: XRAY "Whisper Number" EPS of .69

[Drmicrocap]

IN THE NEWS: P&G beats the "street" by .02

[Drmicrocap]

In The News: JCTCF reports EPS of .21

[Drmicrocap]

IN THE NEWS: SBUX "Whisper Number" .53

[Drmicrocap]

IN THE NEWS: DG "Whisper Number" $1.44

[Drmicrocap]

IN THE NEWS: KKR "Whisper Number" .65

[Drmicrocap]

IN THE NEWS: "WHISPER NUMBER" NWSA .20

[Drmicrocap]

In The News: WMT "Whisper Number" $1.37

[Drmicrocap]

IN THE NEWS: RICK "Whisper Number" .43

[Drmicrocap]

In The News:SONC beats "Earnings Whispers"

[Drmicrocap]

In The News: NWL "Whisper Number" .85

[Drmicrocap]

In The News: NFLX "Whisper Numbers" .30

[Drmicrocap]

IN THE NEWS; RICK BEATS BY .03

[Drmicrocap]

In The News: COST beats by .06

[Drmicrocap]

In The News: COST

[Drmicrocap]

In The News: MSFT

[Drmicrocap]

IN THE NEWS: RAI

[Drmicrocap]

XRAY beats by .03

[Drmicrocap]

IN THE NEWS: TSCO

[Drmicrocap]

TTC

[Drmicrocap]

"Whisper Number"

[Drmicrocap]

Whisper Number

[Drmicrocap]

Whisper Number

The "Street" has NWL coming in at .77 for the 3rd Quarter ended September 2016 that should be reported on or about October 28, 2016.

All comments welcome.

The "Good Dr's In!"

http://www.whispernumber.com/whisper_profile.jsp?ticker=nwl

[Drmicrocap]

NWL beats Revenue and EPS Estimates.

https://finance.yahoo.com/news/newell-rubbermaid-tops-street-2q-104240573.html

[Drmicrocap]

The "Street" has AZZ coming in at .88 for the quarter that should be reported on or about June 29, 2016!

All post's welcome!

The "Good Dr's In"!

[Drmicrocap]

6:37 am Clorox beats by $0.11, beats on revs; raises FY16 guidance (CLX) :

Reports Q3 (Mar) earnings of $1.21 per share, $0.11 better than the Capital IQ Consensus of $1.10; revenues rose 1.8% year/year to $1.43 bln vs the $1.41 bln Capital IQ Consensus.
Co issues raises guidance for FY16, sees EPS of $4.85-4.95 vs. $4.92 Capital IQ Consensus Estimate, up from previous outlook of $4.75 to $4.90. Raises sales growth outlook to 1% to 2% sales growth, or 4% to 5% currency-neutral (previously flat to 1% growth, 3% to 4% currency neutral). Revenue consensus represents +0.8% growth. CLX now sees about 50 basis points of EBIT margin expansion (previously 50-75 basis points).
Third-quarter diluted EPS results were driven largely by gross margin expansion and higher sales, partially offset by higher advertising and sales promotion spending and the impact of unfavorable foreign currency exchange rates.

[Drmicrocap]

The "Street" has XRAY coming in at .65 for the quarter that should be reported on or about May 6, 2016! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

6:36 am Newell Brands beats by $0.02, beats on revs; guides FY16 EPS above consensus (NWL) :

Reports Q1 (Mar) earnings of $0.40 per share, $0.02 better than the Capital IQ Consensus of $0.38; revenues rose 4.0% year/year to $1.31 bln vs the $1.3 bln Capital IQ Consensus. 100 basis point increase in normalized operating margin compared to the prior year, while simultaneously increasing advertising and promotion investment by 40 basis points; 170 basis point increase in reported operating margin compared to the prior year.
Co issues guidance for FY16, sees EPS of $2.75-2.90 vs. $2.60 Capital IQ Consensus Estimate; sees FY16 revs of +3-4% to ~$1.35-1.37 bln, may not be comparable to $13.42 bln Capital IQ Consensus Estimate. As of April 15, 2016, Newell Brands core sales will include pro forma core sales associated with the Jarden transaction as if the combination occurred April 15, 2015. Core sales excludes the impact of foreign currency, all acquisitions until their first anniversary and all planned and completed divestitures (which includes the deconsolidation of Venezuela), but includes the negative impact of planned product line exits.

[Drmicrocap]

The "Street has TZOO coming in at .11 for the quarter that should be reported on or about April 17, 2016! All post's welcome! The "Good Dr's In"!
Sentiment: Strong Buy

[Drmicrocap]

4:39 pm Sonic beats by $0.02, beats on revs; raises FY16 guidance above consensus; finances debt repurchase with new debt offeringBriefing.com (Tue, Mar 29)

[Drmicrocap]

The "Street has AZZ coming in at .70 for the quarter that should be reported on or about April 20, 2016!

All post's welcome!

The "Good Dr's In"!

<eom>

[Drmicrocap]

The "Street" has PG coming in at .85 for the quarter that should be reported on or about April 25, 2016! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

The "Street" has LAD coming in at 1.86 for the quarter that should be reported on or about February 24, 2016! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

Colgate Beats 4Q15 Earnings Estimates but Misses on Sales Again
Market Realist By Penny Morgan
4 hours ago
????
Colgate's 4Q15 Results: Earnings Bring Smiles but Sales Dwindle

Colgate’s 4Q15 financial results
Colgate-Palmolive (CL) released its 4Q15 earnings on January 29, 2016. The quarter ended on December 31, 2015. The company’s reported adjusted diluted EPS (or earnings per share) fell 3.9% to $0.73 per share in 4Q15 compared to $0.76 in 4Q14. Revenue was down 7.5% to $3.9 billion.

However, in 4Q15, Colgate-Palmolive came in ahead of consensus Wall Street analyst estimates on earnings after being in line with the estimates for three quarters in a row. Consensus estimates had projected an adjusted diluted EPS of $0.72.


Diluted EPS
On a currency-neutral basis and excluding the after-tax charges on special items including its 2012 restructuring program, its Venezuela accounting change, and other foreign competition charges, the diluted EPS increased by double digits.

Similarly, Procter & Gamble’s (PG) adjusted EPS fell 1.4% while core adjusted earnings per share increased 9% to $1.04 per share in 4Q15. Excluding the impact of currency exchange headwinds, currency-neutral core EPS increased 21% for the quarter. Adjusted EPS for Kimberly-Clark (KMB) also increased to $1.42 in 4Q15 compared to EPS from continuing operations of $1.35 in 4Q15. Clorox (CLX) is yet to announce its 4Q15 results.

Venezuela operations
During 4Q15, the company announced that it will no longer include the results of its Venezuelan operations in its consolidated financial statements. As a result of this change in accounting, Colgate recorded an after-tax charge of $1.1 billion, or $1.18 per diluted share, in 4Q15. This change reflected a significant decrease in the availability of US dollars and other government controls.

As a result, Colgate expects that the change in accounting for its Venezuelan operation will impact diluted EPS in 2016. The company expects diluted EPS to be negative $0.10 for 2016. Colgate makes up 0.7% of the iShares Global 100 ETF (IOO).

In the next article, we will look at Colgate’s revenue estimates and the components that accounted for the decrease in revenues in 4Q15.

[Drmicrocap]

7:02 am WisdomTree reports EPS in-line, beats on revs (WETF) :

Reports Q4 (Dec) earnings of $0.15 per share, in-line with the Capital IQ Consensus of $0.15; revenues rose 54.2% year/year to $76.5 mln vs the $74.59 mln Capital IQ Consensus.
"In challenging market conditions the benefit of the ETF structure becomes even more apparent. Against a backdrop of $125 billion in mutual fund outflows in 2015, the ETF industry enjoyed $232 billion in net inflows."

[Drmicrocap]

The "Street" has NFLX coming in at .04 for the quarter that should be reported on or about January 19, 2016! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

6:35 am AZZ beats by $0.02, misses on revs; narrows FY16 guidance (AZZ) :
•Reports Q3 (Nov) earnings of $0.91 per share, $0.02 better than the Capital IQ Consensus of $0.89; revenues rose 7.8% year/year to $242.4 mln vs the $249.87 mln Capital IQ Consensus.
•Co narrows guidance for FY16, sees EPS of $2.90-3.10 from $2.85-3.30, excluding non-recurring items, vs. $3.03 Capital IQ Consensus; sees FY16 revs $890-915 mln from $900-940 mln vs. $909.34 mln Capital IQ Consensus Estimate.
•"Our WSI specialty welding business continues to penetrate and gain market share in the global markets that we serve. Quoting activity for the quarter was strong, and the current backlog in our Energy Segment remains solid. In the Galvanizing Service Segment, the market continued to present some challenges in the Gulf Coast region from lower oil prices, but we are gaining strength in other sectors to partially compensate, including bridge and highway and electric utilities."

[Drmicrocap]

The "Street" has NWL coming in at .58 for the quarter that should be reported on or about January 30, 2015! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

The "Street" has CL coming in at .74 for the quarter that should be reported on or about January 20, 2016! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

The "Street has NWL coming in at .57 for the quarter that should be reported on or about January 26, 2015! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

The "Street" has KKR coming in at - .28 for the quarter that should be reported on or about October 27, 2015! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

The "Street" has SWK coming in at 1.56 for the quarter that should be reported on or about October 22, 2015! All post's welcome! The "Good Dr's In"!

[Drmicrocap]

The "Street" has SONC coming in at .44 for the Fourth Quarter that should be reported on or about October 15th 2015! All post's welcome! The "Good Dr's In"!